Blood clot-related strokes decrease among whites for the first time: Study

NewsGuard 100/100 Score

Study highlights:

- Tracking 1.3 million people in the Greater Cincinnati/Northern Kentucky area, researchers found that stroke incidence fell significantly in whites between 1999 and 2005, but not among blacks.

- There was no racial difference in whether a stroke led to death.

The incidence of blood clot-related strokes fell among whites in the Greater Cincinnati/Northern Kentucky area for the first time, according to long-term surveillance study representative of strokes in blacks and whites nationwide reported in Stroke: Journal of the American Heart Association.

However, there was no decrease in stroke rates among blacks.

"It's encouraging that, for the first time ever in our study area, there is a drop in the most common type of stroke," said Dawn Kleindorfer, M.D., lead author of the study and assistant professor of neurology at the University of Cincinnati. "However, it's very disappointing that the racial disparity seems to be getting worse."

Investigators found that the age-adjusted annual rate of ischemic stroke (those caused by a blood clot) resulting in hospitalization changed between 1999 and 2005 from:

  • 189 to 167 per 100,000 overall, an 11.6 percent drop;
  • 180 to 154 per 100,000 among whites, a 14.4 percent reduction;
  • 263 to 275 per 100,000 among blacks, a 4.6 percent rise, but not a significant change.

The patterns remained the same when out-of-hospital strokes were included. During the same period, researchers found no change in the rate of hemorrhagic strokes (those caused by bleeding).

The likelihood of dying after an ischemic stroke remained steady over time and was similar in whites and blacks, about 10 percent, according to the report.

Researchers used data from the Greater Cincinnati/Northern Kentucky Stroke Study, which gathered information on all first strokes occurring in a five-county area with 1.3 million people. The counties include urban, suburban and rural areas. It's comparable to the nation in education, income and in the percentage of blacks (18 percent), but does not include a substantial proportion of persons of Hispanic ethnicity (less than 3 percent).

"When you look at national maps on mortality, you see many more stroke deaths in blacks," Kleindorfer said. "According to our data, this occurs because blacks are far more likely to have a stroke to begin with, not because they are more likely to die once the stroke happens."

The racial disparity could not be explained by differences in the occurrence and treatment of stroke risk factors. According to a telephone survey conducted in the study area, blacks were more likely than whites to have been diagnosed with risk factors such as high blood pressure and diabetes, but they were also more likely to be receiving treatment for these conditions.

"We've done a lot of work in the community to increase stroke awareness and encourage prevention, but the stroke rates are absolutely stable in blacks," Kleindorfer said.

The investigators are collecting 2010 data in their ongoing phase of their epidemiology of stroke project.

Stroke is the third leading cause of death in the United States and a leading cause of major disability in adults.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New RNA therapy zilebesiran shows promise in lowering blood pressure